Friday, June 6, 2008

B3: Update on Renovascular Disease: Judgments and Techniques of Revascularization
SDCC: Room 6C

Moderator: Matthew S. Edwards, MD
Wake Forest University, Winston-Salem, N.C.

At the end of this session, the participant will be able to:

1. Describe and apply to his/her practice the natural history of renovascular disease.
2. Describe and apply to his/her practice the current indications for surgical and endovascular revascularization in renovascular disease.
3. Describe and apply to his/her practice the current evidence regarding embolic protection and endovascular renal revascularization.
4. Better understand current reimbursement and coverage decisions regarding the treatment of renovascular disease from the Centers for Medicare and Medicaid Services.
    
7:00 am
Welcome and Introductory Remarks
Matthew S. Edwards, MD, Wake Forest University, Winston-Salem, N.C. 
    
7:05 am
Natural History of Renovascular Disease
Randolph L. Geary, MD, Wake Forest University, Winston-Salem, N.C.
    
7:16 am
Current Indications for Revascularization and an Update on Ongoing Clinical Trials
Christopher Cooper, MD, University of Toledo Medical Center, Toledo Ohio
     
7:31 am
Renal Artery Stenting: In Whom and How?
Christopher J. Kwolek, MD, Massachusetts General Hospital, Boston, Mass.

7:44 am
Surgical Revascularization: What Have We Learned?
Kimberley J. Hansen, MD, Wake Forest University, Winston-Salem, N.C. 
  
7:57 am
Embolic Protection: Is There a Role in Renal Stenting?
Jade S. Hiramoto MD, University of California-San Francisco, San Francisco, Calif.

8:08 am
Current Controversies in Coverage of Renal Revascularization
Robert M. Zwolak, MD, Dartmouth-Hitchcock Medical Center, Lebanon, N.H.
   
8:20 am
Panel Discussion

B4: Endovascular AAA Repair: What's New?
SDCC: Room 6F

Supported by an educational grant from Medtronic.

Moderator: W. Anthony Lee, MD, FACS
University of Florida College of Medicine, Gainesville, Fla.

At the end of this session, participants should be able to:
1. To review the current status of fenestrated aortic endografts, iliac branch devices.
2. To learn the role of aortouni-iliac devices in the endovascular treatment of AAA.
3. To review the differences and similarities of new investigational devices for EVAR.
4. To learn new techniques for treatment of endoleaks.
5. To review the techniques and outcomes of percutaneous access during EVAR. 

7:00 am
Welcome/Introduction
W. Anthony Lee, MD, University of Florida College of Medicine, Gainesville, Fla.

7:05 am
Overcoming the Perivisceral Aorta: Fenestrated Aortic Endografts
Christopher J. Kwolek, MD, Massachusetts General Hospital, Boston, Mass.

7:15 am
Hypogastric Preservation: Iliac Branch Devices
Peter H. Lin, MD, Baylor College of Medicine, Houston, Texas

7:25 am
New Devices for EVAR: Differences and Similarities
Neal S. Cayne, MD, NYU Medical Center, New York, N.Y.

7:35 am
Percutaneous Endovascular Aortic Repair
W. Anthony Lee, MD, University of Florida College of Medicine, Gainesville, Fla.

7:45 am
Latest Management Strategies of Type I and II Endoleaks (e.g. Endostapler, Foams, etc.)
Luis A. Sanchez, MD, Washington University School of Medicine, St. Louis, Mo.

7:55 am
Role of Aorto-uniliac Devices in a Bifurcated World
Peter R. Nelson, MD, University of Florida College of Medicine, Gainesville, Fla.

8:05 am
Panel Discussion

Moderators: Richard P. Cambria, MD
Massachusetts General Hospital, Boston, Mass.

Amy B. Reed, MD
University of Cincinnati Medical Center, Cincinnati, Ohio

At the end of this session, participants should be able to:

1. Discuss the methodology, results and conclusions of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis and treatment of vascular disease.

SS18. SVS Carotid Vascular Registry: CAS vs. CEA Outcomes Comparison
Anton N. Sidawy¹, Robert M. Zwolak², Rodney A. White³, Flora S. Siami⁴, Marc L. Schermerhorn⁵, Gregorio A. Sicard⁶, SVS Outcomes Committee.
¹VA Medical Center, Washington, D.C. ²Dartmouth-Hitchcock Medical Center, Lebanon, N.H.;³Harbor-UCLA Medical Center, Torrance, Calif.;⁴New England Research Institutes, Inc, Watertown, Mass.;⁵Beth Israel Deaconess Medical Center, Boston, Mass.;⁶Washington University, St. Louis, Mo.

SS19. Outcomes After Carotid Endarterectomy: Is There a High-Risk Population? A National Surgical Quality Improvement Program Report
Jeanwan Kang, Thomas K. Chung, Vikram Paruchuri, Robert T. Lancaster, Matthew M. Hutter, Glenn M. LaMuraglia, Mark F. Conrad, Richard P. Cambria.
Massachusetts General Hospital, Boston, Mass.

SS20. Long-Term Results of Carotid Artery Stenting
Gianmarco de Donato¹, Carlo Setacci¹, Koen Deloose2, Jurgen Verbist3, Patrick Peeters3, Fausto Castriota4, Alberto Cremonesi4, Marc Bosiers.2
1Department of Vascular and Endovascular Surgery, University of Siena, Siena, Italy;2Department of Vascular Surgery, AZ St-Blasius, Dendermonde, Belgium;3Department of Cardiovascular and Thoracic Surgery of the Imelda Hospital, Bonheiden, Belgium;4Interventional Cardio-Angiology Unit, Villa Maria Cecilia Hospital, Cotignola (RA), Italy.

SS21. Intracranial Hemorrhage After Carotid Endarterectomy and Carotid Artery Stenting in the United States in 2005
Carlos H. Timaran1, Eric B Rosero1, Frank J. Veith2, John G. Clagett1, Rawson J. Valentine1, Stephen T. Smith1, G. Patrick Clagett.1
1University of Texas Southwestern Medical Center, Dallas, Texas;2Cleveland Clinic Foundation, Cleveland, Ohio.

SS22. Silent CT-Brain Embolic Infarcts and Risk of Ipsilateral Hemispheric Events and Stroke in Patients with Asymptomatic Internal Carotid Artery Stenosis
Steve Kakkos, Michael Sabetai, Thomas Tegos, John Stevens, Maura Griffin, George Geroulakos, Andrew N. Nicolaides.
Imperial College, London, United Kingdom.

S5: SVS Plenary Session
SDCC: Room 6AB

Moderators: Roy K. Greenberg, MD
Cleveland Clinic Foundation, Cleveland, Ohio

Gregory J. Pearl, MD
Texas Vascular Associates, Dallas, Texas

At the end of this session, participants should be able to:

1. Discuss the methodology, results and conclusions of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis and treatment of vascular disease.

SS23. Late-Breaking Clinical Trial
Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy: First 2,000 Patients from the SAPPHIRE Worldwide Registry
Doug Massop¹, Rajesh M. Dave², Christopher Metzger³, William Bachinsky⁴, Maurice Solis⁵, Rasesh Shah⁶, Greg Schultz⁷, Theodore Schreiber⁸, Majdi Ashchi⁹, Robert Hibbard¹⁰, and Amy Orlick¹¹ for the SAPPHIRE Worldwide Investigators.
¹The Iowa Clinic, Des Moines, IA;²Central PA CV Research Institute, Harrisburg, PA;³Holston Valley Medical Center, Kingsport, TN;⁴Pinnacle Health at Harrisburg, Harrisburg, PA;⁵Medical Center of Central Georgia, Macon, GA;⁶Sentara Norfolk General Hospital, Norfolk, VA;⁷Sioux Valley Clinic, Sioux Falls, SD;⁸Harper University Hospital, Detroit, MI;⁹Memorial Medical Center, Jacksonville, FL;¹⁰Bruan LGH Heart Institute, Lincoln, NE;¹¹Cordis Corporation, Warren, NJ

SS24. Predicting One Year Mortality After Elective AAA Repair: When NOT to Operate
Adam W. Beck¹, Phillip P. Goodney¹, Brian W. Nolan¹, Donald S. Likosky¹, Jens Jorgensen², Jack L. Cronenwett¹, for The Vascular Study Group of Northern New England (VSGNNE).
¹Dartmouth-Hitchcock Medical Center, Lebanon, N.H.;²Maine Medical Center, Portland, Maine.

SS25. Fenestrated Endovascular Repair for Juxtarenal Aortic Pathology
Thorarinn Kristmundsson, Krasnodar Ivancev, Martin Malina, Björn Sonesson, Katarina Björses, Nuno Dias, Timothy Resch.
University Hospital, Malmo, Sweden.

SS26. Isolated Gastro/Soleal Deep Venous Thrombosis is Associated with Pulmonary Embolism and a High Incidence of Additional Ipsilateral and Contralateral DVT.
Nicole M. Wheeler, Tim K. Liem, Erica L. Mitchell, Gregory J. Landry, Gregory L. Moneta
Oregon Health & Science University, Portland, Ore.

SS27. Risk Stratification in Critical Limb Ischemia (CLI): Derivation and Validation of a Simplified Model to Predict Amputation-Free Survival (AFS) Using Multi-Center Surgical Outcomes Data
Andres Schanzer¹, Jessica Mega², Judith Meadows³, Russell H. Samson⁴, Dennis F. Bandyk⁵, Michael S. Conte.^3
1University of Massachusetts Medical School, Worcester, Mass.;²Massachusetts General Hospital, Boston, Mass.;³Brigham and Women's Hospital, Boston, Mass.;⁴Florida State University, Sarasota, Fla.;⁵University of South Florida, Tampa, Fla.

SVS Member Business Luncheon
SDCC: Room 6C

C1: Joint ESVS/SVS Program
SDCC:  Room 1AB

European Vascular Developments

Moderator: Peter Gloviczki, MD
Mayo Clinic, Rochester, MN

John H. N. Wolfe, FRCS, FEVBS, MS
St Mary's Hospital, United Kingdom

At the end of this session, participants should be able to:

1. Assess which intervention, surgical bypass or PTA, is best for patients suffering critical limb ischaemia.
2. Define the predictive value on non-invasive screening of asymptomatic persons.
3. Determine when stent-grafting is preferable for diseases of the thoraco-abdominal aorta.
                                                                        
2:15 pm
European Biobanks: What Can They Be Used For
Frans Moll, MD, PhD
University Medical Center Utrecht, The Netherlands

2:33 pm
The Impact of Stents on the Thoraco-Abdominal Aorta
John H. N. Wolfe, FRCS, FEVBS, MS
St Mary's Hospital, United Kingdom

2:51 pm
Screening for Vascular Disease – Does it Matter?
Henrik Sillesen, MD, DMSc
University of Copenhagen, Denmark

3:09 pm
The Bypass vs. Angioplasty in Severe Ischemia of the Leg (BASIL) Trial
Andrew Bradbury, MD, PhD
University of Birmingham, United Kingdom

3:27 pm
Panel Discussion

C2: Perception vs. Reality: Lessons from the SVS Public Perception Survey
Sponsored by SVS Communications Committee
SDCC: Room 5AB     

Moderator: George H. Meier, MD
University of Cincinnati School of Medicine, Cincinnati, Ohio

At the end of this session, participants should be able to:

1. Analyze data from the public perception survey relative to vascular surgery.
2. Use the SVS branding toolkit to brand their own practices.
3. Implement other branding techniques successful for vascular surgical programs.   

2:15 pm
Introduction
George H. Meier, MD
University of Cincinnati School of Medicine, Cincinnati, OH

2:20 pm            
Results from the Referring Physician’s Survey: Why Do Physicians Refer?
Linda M. Harris, MD
SUNY at Buffalo Graduate Medical, Buffalo, NY

2:30 pm
The Public’s Perspective on Vascular Surgery
John Blebea, MD
Temple University Hospital, Philadelphia, PA

2:40 pm
Recommendations from the Two Surveys for the Future
Samuel R. Money, MD
Mayo Clinic Scottsdale, Scottsdale, AZ

2:50 pm
What’s in a Name: Should We Be Surgeons or Specialists?
G. Patrick Clagett, MD
University of Texas Southwestern Medical Center, Dallas, TX

3:00 pm
Marketing How-to:
1. Marketing Vascular Surgery in a Rural Academic Practice
Spence M. Taylor, MD
Greenville Hospital System, Greenville, SC

3:10 pm
Marketing How-to:                           
2. Marketing Vascular Surgery in an Urban Academic Practice
Alan B. Lumsden, MD
Methodist DeBakey Heart Center, Houston, TX

3:20 pm
Panel Discussion

C3: Peripheral Vascular Surgery Society Papers
SDCC: Room 11AB

At the end of this session, participants should be able to:

1. Understand the choices for imaging of vascular diseases and their limitations.
2. Appreciate the role of open and endovascular procedures for carotid therapy.
3. Review the current status and outcomes of treatment for thoracic and abdominal aneurysms.
4. Understand the management options and limitations for treatment of lower extremity occlusive disease.
5. Appraise novel therapies for vascular disease.

2:15 pm
PVSS1. Carotid Stenting and Endarterectomy in the United States: Age and Outcomes

2:30 pm
PVSS2. Intraoperative SSEP Monitoring During Carotid Endarterectomy – Is it Enough?

2:45 pm
PVSS3. Reduction of Post-Procedure Microemboli Following Retrospective Quality Assessment and Practice Improvement Measures for Carotid Angioplasty and Stenting

3:00 pm
PVSS4. Open-Cell vs. Closed-Cell Stent Design Differences in Blood Flow Velocities After Carotid Stenting

3:15 pm
PVSS5. Simultaneous Pre- and Post-Filter Transcranial Doppler Monitoring During Carotid Artery Stenting

3:30 pm
PVSS6. Carotid Artery Stenting in Women Is a Safe Procedure with Equivocal Outcomes Compared to Men

To identify ways in which vascular groups, academic and private, can access new resources to facilitate their ongoing growth and development.

At the end of this session, participants should be able to:
1. Understand how outpatient procedures can be incorporated into an office based practice to increase reimbursement.
2. Evaluate the advantages and disadvantages of different models to incorporate vascular medicine into a vascular surgery practice.
3. Understand the implications of the newest STARK provisions as they relate to self referral in vascular practice.
4. Understand the role that philanthropy and targeted giving can play in the development of a vascular disease program.
    
3:00 pm
Introduction
Moderator: John J. Ricotta, MD
SUNY at Stony Brook, Stony Brook, N.Y.     

3:05 pm 
Incorporating Office-Based Procedures into Vascular Practice
Enrico Ascher, MD
Maimonides Medical Center, Brooklyn, N.Y.

3:20 pm
Panel Discussion

3:30 pm 
Vascular Medicine: Buy it or Grow it
Paul B. Kreienberg, MD
The Vascular Group, PLLC, Albany Medical Center Hospital, Albany, N.Y.

3:45 pm 
Panel Discussion     

Moderator: Michel S. Makaroun, MD
Presbyterian University Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pa.

3:55 pm 
Stark 2008: What it Means to You
O. William Brown MD, JD
Wayne State University School of Medicine, Detroit, Mich.

4:10 pm 
Panel Discussion

4:20 pm 
The Role of Philanthropy in Developing a Vascular Disease Program
William H. Pearce, MD
McGaw Medical Center of Northwestern, Chicago, Ill.  

Moderator: Peter F. Lawrence, MD
UCLA Medical Center, Los Angeles, Calif.
     
4:35 pm 
Recap/Questions and Answers

Concurrent Breakout Sessions

C5: How I Do it: Video Potpourri Session
SDCC: Room 1AB

Moderator: Peter L. Faries, MD
Mount Sinai School of Medicine, New York, N.Y.

At the end of this session, participants should be able to:

1. Become familiar with techniques for the treatment of vascular disease including thoracic and abdominal aortic aneurysms, popliteal artery aneurysms, carotid artery stenosis and lower extremity ischemia.
2. Learn alternative approaches to each of these disease entities.
3. Learn the indications for intervention for each of these disease entities.
4. Become aware of potential complications and pitfalls encountered during the treatment of each disease. 

4:15 pm                                                             
Endovascular Repair of Thoracic Aneurysms and Aortoenteric Fistulae
Alfio Carroccio, MD, Mount Sinai School of Medicine, New York, N.Y.
Michael L. Marin, MD, Mount Sinai School of Medicine, New York, N.Y.

4:30 pm
Current Approaches to Popliteal Aneurysm Repair: Endovascular and Standard Surgical Management
Neal S. Cayne, MD, New York University Medical Center, New York, N.Y.  
                                                                                  
4:45 pm
How I Do Eversion Carotid Endarterectomy
Mark Conrad, MD, Massachusetts General Hospital, Boston, Mass.

5:00 pm
Re-Entry Techniques as Adjuncts to Subintimal Angioplasty for the Treatment of Lower Extremity Ischemia
Donald L. Jacobs, MD, St. Louis University Medical Center, St. Louis, Mo.

5:15 pm                                                                
Thoracoabdominal and Flank Incisions in the Repair of Complex Aortic Disease
James H. Black, MD, Johns Hopkins Hospital, Baltimore, MD

5:30 pm
Panel Discussion

At the end of this session, participants should be able to:

1. Understand the choices for imaging of vascular diseases and their limitations.
2. Appreciate the role of open and endovascular procedures for carotid therapy.
3. Review the current status and outcomes of treatment for thoracic and abdominal aneurysms.
4. Understand the management options and limitations for treatment of lower extremity occlusive disease.
5. Appraise novel therapies for vascular disease.

4:15 pm
PVSS7. The Phase I Multicenter Trial of the Aptus™ Endovascular Repair System: Results at Six Months and One Year

4:30 pm
PVSS8. Outcomes of Endovascular Abdominal Aortic Aneurysm Repair Compared to Open Surgical Repair In High-Risk Patients: Results from the Swedish Vascular Registry

4:45 pm
PVSS9. Thoracic Endografts for Chronic Type B Aortic Dissections

5:00 pm
PVSS10. TEVAR Following Prior Abdominal Aortic Aneurysm Surgery: What Is the Risk of Neurological Deficit?

5:15 pm
PVSS11. A Prospective Analysis of Endovascular Ruptured AAA Repair in Hemodynamically Stable vs. Unstable Patients

5:30 pm
PVSS12. Ultrasound Surveillance After Endovascular Aneurysm Repair (EVAR): Are CT Scans Still Necessary?

C7: How to Review a Scientific Paper for JVS: A View from the Editors’ Desk
SDCC: Room 5AB

Moderators: Jack Cronenwett, MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH

James M. Seeger, MD
University of Florida Gainesville, College of Medicine, Gainesville, FL                                                                                 

At the end of this session, participants should be able to:

1. Read and review a scientific paper.
2. Assess the strengths and limitations of a research study design.
3. Review the statistical analysis of presented research data.
4. Write a better review for both the editors and the authors.

4:15 pm
Reviewing a Manuscript: Basic Goals
Bruce A. Perler, MD
Johns Hopkins University, Baltimore, MD

4:25 pm
Reviewing the Study Design: Strengths and Pitfalls
James M. Seeger, MD
University of Florida Gainesville, College of Medicine, Gainesville, FL
                                                                                               
4:40 pm
Reviewing the Statistical Analysis: Did They Get it Right? The Statistician’s View
Louise C. Brown
Imperial College London, London, UK           

5:00 pm
The Clinician’s View
James M. Seeger, MD
University of Florida Gainesville, College of Medicine, Gainesville, FL

5:10 pm
Issues in Reviewing Basic Science Articles
Louis M. Messina, MD, University of Massachusetts Medical School, Worcester, MA

5:20 pm
Writing a good review
Jack Cronenwett, MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH

5:35 pm
Panel Discussion